Target Healthcare REIT (LON:THRL) Hits New 12-Month High – Still a Buy?

Target Healthcare REIT (LON:THRL)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 113 and last traded at GBX 110.60, with a volume of 34288 shares trading hands. The stock had previously closed at GBX 110.76.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Target Healthcare REIT currently has an average rating of “Hold” and a consensus target price of GBX 101.

Target Healthcare REIT Stock Up 0.0%

The firm has a market cap of £687.22 million, a PE ratio of 8.81, a P/E/G ratio of 1.48 and a beta of 0.54. The firm has a 50-day moving average price of GBX 107.18 and a two-hundred day moving average price of GBX 104.40.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.